Flo has raised $269 million across Series A, Series B, and Series C funding rounds, achieving unicorn status with a $1 billion valuation. The company’s funding has supported the expansion of its AI-driven women’s health platform, global user growth, and advanced predictive health insights. Backed by investors such as General Atlantic and Target Global, Flo continues to strengthen its position as a leading AI-powered menstrual and reproductive health platform.